US (MA): Grower receives $50M investment

CapStone Holdings has invested a $50 million stake in Curaleaf.

"Curaleaf was a logical choice for CapStone because one of the company's primary focuses is improving the quality of people's lives," said Heather Stone of CapStone Holdings, Inc. "A growing number of states are permitting physicians to prescribe cannabis-based medicines to address a range of health issues, including pain management, cancer, glaucoma, and seizures."

"Curaleaf has quickly become a leader in a $16 billion industry through thoughtful acquisitions, licensing, product development and expansion of retail dispensaries into new markets across the country," said CapStone Holdings Chairman & Founder Keith J. Stone. "Curaleaf is well-positioned for continued growth and expansion across the U.S."